Nervotec is the world’s first provider of HaaS (Healthcare as a Service), a software only solution that measures and analyses physiological biomarkers remotely and contactlessly across multiple mobile platforms.

Nervotec’s proprietary video-based technology enables the rapid measurement of physiological biomarkers with medical grade accuracies, while creating actionable insights on stress and heart health.

Nervotec’s solutions are used in professional sports, construction, insurance, healthcare, and governmental sectors worldwide.

Through its technologies, Nervotec is transforming the way people access healthcare, truly enabling healthcare anywhere.

SunGreenH2 is an award-winning startup building the world’s highest performance water electrolysis technology
that doubles (2x) production of green hydrogen while significantly reducing platinum group metal loading and energy consumption. Our proprietary component technology is the result of over 10 years of research in nanotechnology and electrochemistry. The company is currently working with leading electrolyser manufacturers and hydrogen end users to bring its products to market.

We develop automatic speech recognition (ASR) SaaS solutions. Our ASR engines are developed by our Co-founder, Ian Lane, one of the best R&D teams at Carnegie Mellon University. Our recent product, Auris Edit, aims to make digital content accessible to the world.
Auris Edit enables content creators to easily create caption, transcription and inserting foreign subtitles, reducing their 50% of post-editing time. Creators can spend more time on contents creation rather than on less creative editing processes.
Our primary target is light users like mid-entry level YouTubers, or freelancers who help top YouTubers to add captions/subtitles. YouTube has over 50m content creators, and only with YouTube, we expect that the demand is high.
Captions/Subtitles are a must-have feature for content creators because 60% of YouTube views are from non-native English speakers, say people in South East Asia!
So Auris Edit will first target Asian market making digital content accessible.

Ampotech develops internet of things (IoT) hardware and AI-enabled software to help businesses collect, analyze, and integrate electricity usage data from the built environment to deliver intelligent solutions and services. Launched in 2015 and headquartered in Singapore, Ampotech is supported by investors from the electronics, telecommunications, and deep tech sectors, with customers throughout the Asia Pacific region in industries such as energy & facility services, commercial real estate, manufacturing, and utilities.

At Craft Health, we are building a platform for 3D printed personalized healthcare. Possible applications include personalized nutrition, decentralized clinical trials, personalized medicine, and 3D printing for orphan drugs.

Since we launched in May 2019, we have:

・Hardware: In-house developed 3D printer specialized for nutraceuticals and pharmaceuticals. Our 3D printer is designed for Good Manufacturing Practice (GMP) and the 3D printing process does not involve heat or ultraviolet (UV) curing, enabling a wide range of active ingredients to be used.
・Software: 3D printing software
・3D printable formulations: A series of proprietary 3D printable formulations for different controlled released profiles (Immediate/sustained/delayed release) that can be combined in a single 3D printed tablet.
・Specialty products: Patent pending 3D printed capsule that converts once daily dosing to once weekly.

Widuz is developing a new class of renewable and sustainable material called BVL™ (Bamboo Veneer Lumber), which is a high-performance patented structural lumber synthesized from bamboo fibres. BVL is up to 3 times stronger than timber while is not susceptible to any decay or degradation, and is much more dimensionally stable. BVL is suitable for construction of modular prefab buildings in place of other non-renewable construction materials such as concrete and steel.

The global drone market was valued at USD 18.11 Bn in 2018 with a CAGR of 19.90% and is expected to reach 88.57 Bn by the end of 2027. While hardware companies continue to improve drone technology, drone service providers are creating solutions that provide an excellent return on investment. However the next five years will be about leveraging drone data to integrate, automate, and communicate multiple streams of data. Our team has the know-how to inform about the human and environmental factors in large workplaces. As drone hardware advances, more industries will bring this technology in-house reducing the need for service providers. Our technology bridges this transition by fusing the physical and digital to address present needs for a reformation of the work place.

Our platform as a service provides and integrates 2D maps and 3D digital twins of large spaces, real time tracking and various sensors, to address fast and slow disasters and their surrounding industries including insurance, real estate, construction, and renewable energy. Our software aims to change the way these industries communicate across stakeholders, allocate resources, and think about safety protocols. Our product can be thought of as workplace building blocks for the ‘new normal’.

JN Medsys is a Singapore biomedical company dedicated to providing super resolution genomic tools for precise and personalized diagnostics. Founded in 2010, our vision is to improve lives through advanced diagnostics in healthcare. We have been working relentlessly over the years to create cutting-edge genomic tools, comprising instruments and kits, that provide better sensitivity and accuracy for nucleic acids analysis. Through these advanced diagnostics, we hope to generate actionable insights to improve the outcomes of cancer and to eradicate infectious diseases. More recently, we have developed an end-to-end solution for Covid-19 testing. Our test is able to provide accurate, fast, and high capacity Covid-19 testing, even for countries which have limited resources.